Recondo Technology Closes $16 million Funding Round to Support Exponential Growth to Power the Healthcare Revenue Cycle
Curevo’s lead program is CRV-101, an adjuvanted subunit vaccine for shingles, which has demonstrated robust immunogenicity and tolerability in…
Acquisition marks Intelerad’s third in six months, expanding the organization’s ability to provide enterprise imaging and insights and…
FundamentalVR secures Series B growth investments to disrupt the medical simulation market – expected to be worth $4.2…